Sindbis Virus with Anti-OX40 Overcomes the Immunosuppressive Tumor Microenvironment of Low-Immunogenic Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sindbis Virus with Anti-OX40 Overcomes the Immunosuppressive Tumor Microenvironment of Low-Immunogenic Tumors

Published:2020-06 Issue: Volume:17 Page:431-447
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Scherwitzl Iris,Opp Silvana,Hurtado Alicia M.,Pampeno Christine,Loomis Cynthia,Kannan Kasthuri,Yu Minjun,Meruelo Daniel

Funder

NIH

Cynvec

NYU Langone

Experimental Pathology Research Laboratory at NYU Langone

Cancer Center

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference94 articles.

1. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat. Rev. Cancer,2012

2. The future of immune checkpoint therapy;Sharma;Science,2015

3. Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade;Wei;Cell,2017

4. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy;Li;Nat. Rev. Clin. Oncol.,2019

5. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies;Galon;Nat. Rev. Drug Discov.,2019

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy;Nature Protocols;2024-05-20

2. Sindbis Virus Vaccine Platform: A Promising Oncolytic Virus-Mediated Approach for Ovarian Cancer Treatment;International Journal of Molecular Sciences;2024-03-02

3. Anti-OX40 Antibody Combined with HBc VLPs Delays Tumor Growth in a Mouse Colon Cancer Model;BIOMED ENVIRON SCI;2024

4. Tumor-derived autophagosome vaccines combined with immune adjuvants mediate antitumor immune responses via the neoantigen pathway;Neoplasma;2024

5. Perspectives for applying Alphaviruses in antitumor therapy;Russian Journal of Infection and Immunity;2023-10-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3